Mycophenolate sodium

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Organ rejection in allogeneic renal transplants, Prophylaxis

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Brand Name:

Myfortic

Project Line:

Reimbursement Review

Project Number:

SR0034-000

Submission Type:

Initial

Indications:

Organ rejection in allogeneic renal transplants, Prophylaxis

Recommendation Type:

List in a similar manner to other drugs in class

Final Recommendation:

July 8, 2005

Recommendation:

List in a similar manner as drug plans list mycophenolate mofetil tablets and capsules.

Last Updated : March 3, 2005